Taiwan chip into biotechnology "We want to biotechnology innovation and commercialization of an indispensable partner." Author: Alan. ALLEN T. Cheng) Taiwan's Hsinchu Technology Industrial Park is a guide to anyone's expectation that it is possible to rank into Jingyu Biotechnology Co., Ltd. (Dr. Chip Biotechnology). A guard stands on a waist and a guard stand outside the gate. He will let you go in a carefully to check your handbag and call the CEO office. Doctoral myself - WANG Shin-Hwan is not so nervous. However, he is also careful when showing the bioconag chip that detects a virus. In the office in Taiwan's Hsinchu Technology Industrial Park, he put his chip like a goat skin like a preservation of jewelry. These chips have a DNA encoding of viruses, which can look for DNA formats that match them in blood samples and saliva. "These are the first bio-chip in the market," Wang Xianhuang said. He clamps the chip of the sized size with a plastic pliers. "They allow hospitals to identify diseases infected in patients within six hours." Jingyu has just established a year, but has become one of the cocaplers of the biotechnology industry. Its development has also given investors and the Taiwan authorities quite hope. Taiwan is a semiconductor and computer industry important design and manufacturing center. But mainland China is attracting more and higher technology investments with low cost and large number of technical talents, including investment from Taiwan's nearly 20 billion US dollars in the past two years. This makes the Taiwan authorities more fear that its resources have been excavated by the mainland. The success of Jingyu as a pioneering pioneer showed that Taiwan still continued to maintain the status of the technology center. This is also the reason why the Taiwan authorities put hundreds of billions of funds into the field of biotechnology. The Taiwan authorities have just opened a partition for the Bioshi Industrial Park for Biotechnology, including seven companies, including Jingyu, will soon migrate there. The Taiwan authorities are still building two similar industrial parks. Industrial gardens will access $ 850 million in government R & D funds through convenient channels, as well as $ 4 billion government and private risk funds, plus a wide range of support services including product promotion and application of global patents. President Chen Shui-bian has said that the Taiwan authorities hope that 500 biotechnology companies can be cultivated in 2010, including at least one global company. Obviously, Taiwan has an entrepreneur, logistics, technical and financial advantages. But Melbourne tracks Asian biotechnology Allen. Alan Carroll said that Taiwan is relatively weak in combining companies with academic achievements. "They put more energy in product development, rather than truly valuable R & D activities." He said. This critical opinion may not be never. "Taiwan's company will never want to become the main driving force for reform." Johnsee Lee, Executive Vice President, Taipei Industrial Technology Research Association (ITRI). "We want to be an indispensable partner in biotechnology innovation and commercialization." For this purpose, ITRI is helping Taiwan's startups and the world's biotechnology companies to form alliances. Ironically, this also includes companies in mainland China. Capital Biochip, China Development Industry Bank, Taiwan, was jointly established in the Aviva, headquartered in Taiwanese, China Development Industry Bank and Capital Biochip in Beijing. Aviva has become a leading chip research institution. Such chips can be used to isolate the compounds to accelerate the development of new drugs. The Wang Dianhuang of Jingyu Company is also urgent to work with the mainland. "We hope to get our product in mainland China as soon as possible," he said. "Let us cooperate with each other, not you die, I live." Taiwan authorities may hope that biotechnology can guarantee Taiwan's economic independence, but it may bring more interdependence factors. Translator: Xu Meishan
wealth
